Int Med - Digestv & Liver Dis

Medicine & Life Sciences

1. Hepatocellular Carcinoma 100%
2. Acute Liver Failure 75%
3. Liver 74%
4. Barrett Esophagus 72%
5. Fibrosis 58%
6. Liver Transplantation 49%
7. Cholesterol 40%
8. Hepacivirus 37%
9. Gastroesophageal Reflux 33%
10. Therapeutics 30%
11. Hepatitis C 30%
12. Liver Diseases 28%
13. Survival 27%
14. Acetaminophen 27%
15. Biliary Liver Cirrhosis 25%
16. Neoplasms 25%
17. Sterols 24%
18. Chronic Hepatitis C 23%
19. LDL Receptors 20%
20. Inflammatory Bowel Diseases 19%
21. Non-alcoholic Fatty Liver Disease 19%
22. Bile Acids and Salts 19%
23. Serum 19%
24. Wounds and Injuries 17%
25. Adenocarcinoma 17%
26. Colorectal Neoplasms 17%
27. Proton Pump Inhibitors 16%
28. Epithelial Cells 16%
29. Interferons 16%
30. Ribavirin 16%
31. Colonoscopy 16%
32. Biomarkers 15%
33. Antiviral Agents 15%
34. Genes 15%
35. Mortality 14%
36. Liver Neoplasms 14%
37. Proteins 14%
38. Esophagus 14%
39. Hepatitis 14%
40. Biopsy 14%
41. Transplants 13%
42. Acids 13%
43. Eosinophilic Esophagitis 13%
44. Chemical and Drug Induced Liver Injury 13%
45. Hepatitis B virus 13%
46. Safety 13%
47. Virus Diseases 12%
48. Endoscopy 12%
49. Pharmaceutical Preparations 12%
50. Metaplasia 12%
51. Incidence 12%
52. Hepatocytes 12%
53. Inflammation 12%
54. Stomach 11%
55. Hemorrhage 11%
56. Infections 11%
57. Confidence Intervals 11%
58. T-Lymphocytes 11%
59. End Stage Liver Disease 11%
60. Hepatitis B 11%
61. Fatty Acids 11%
62. Chronic Hepatitis B 11%
63. Fatty Liver 11%
64. LDL Lipoproteins 11%
65. Sterol Regulatory Element Binding Proteins 10%
66. Epithelium 10%
67. Sterol Regulatory Element Binding Protein 1 10%
68. Antibodies 10%
69. Messenger RNA 10%
70. alpha-Fetoproteins 10%
71. Meta-Analysis 10%
72. Systematic Reviews 10%
73. Ursodeoxycholic Acid 10%
74. Genotype 10%
75. Aspirin 10%
76. Endoscopic Retrograde Cholangiopancreatography 9%
77. Carcinogenesis 9%
78. Esophagitis 9%
79. Cohort Studies 9%
80. Esophageal Neoplasms 9%
81. Early Detection of Cancer 9%
82. Anti-Inflammatory Agents 9%
83. Colitis 9%
84. LDL Cholesterol 9%
85. Guidelines 9%
86. Liver Cirrhosis 9%
87. Population 9%
88. Ulcerative Colitis 9%
89. Peptic Esophagitis 9%
90. Transplantation 9%
91. Odds Ratio 8%
92. Transplant Recipients 8%
93. Gastroenterology 8%
94. Proprotein Convertase 9 8%
95. Mutation 8%
96. Alcohols 8%
97. Gene Expression 8%
98. Tissue Donors 8%
99. Lymphocytes 8%
100. Esophagogastric Junction 8%